NO20081488L - Fotostabil farmasoytisk sammensetning inneholdende brivudine til behandling av herpetisk keratitt - Google Patents

Fotostabil farmasoytisk sammensetning inneholdende brivudine til behandling av herpetisk keratitt

Info

Publication number: NO20081488L
Authority: NO; Norway
Prior art keywords: composition containing; photo; treatment; pharmaceutical composition; stable pharmaceutical
Prior art date: 2005-09-29

Application number

NO20081488A

Other languages

English (en)

Norwegian (no)

Inventor

Marc Wihsmann

Reinhard Schmitz

Original Assignee

Berlin Chemie Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-09-29

Filing date

2008-03-26

Publication date

2008-03-26

2008-03-26 Application filed by Berlin Chemie Ag filed Critical Berlin Chemie Ag

2008-03-26 Publication of NO20081488L publication Critical patent/NO20081488L/no

Links

229960001169 brivudine Drugs 0.000 title abstract 2
ODZBBRURCPAEIQ-PIXDULNESA-N helpin Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(\C=C\Br)=C1 ODZBBRURCPAEIQ-PIXDULNESA-N 0.000 title abstract 2
208000005100 Herpetic Keratitis Diseases 0.000 title 1
206010073938 Ophthalmic herpes simplex Diseases 0.000 title 1
201000010884 herpes simplex virus keratitis Diseases 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
239000004372 Polyvinyl alcohol Substances 0.000 abstract 2
229920000058 polyacrylate Polymers 0.000 abstract 2
229920002451 polyvinyl alcohol Polymers 0.000 abstract 2
229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 2
239000001267 polyvinylpyrrolidone Substances 0.000 abstract 2
235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 2
239000004480 active ingredient Substances 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Virology (AREA)
Inorganic Chemistry (AREA)
Engineering & Computer Science (AREA)
Ophthalmology & Optometry (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Biotechnology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

NO20081488A 2005-09-29 2008-03-26 Fotostabil farmasoytisk sammensetning inneholdende brivudine til behandling av herpetisk keratitt NO20081488L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE102005046769A DE102005046769A1 (de)	2005-09-29	2005-09-29	Lichtstabile, brivudinhaltige pharmazeutische Formulierung zur Behandlung von Augenherpes (Herpes Ophthalmicus)
PCT/EP2006/009383 WO2007039201A2 (en)	2005-09-29	2006-09-27	Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis

Publications (1)

Publication Number	Publication Date
NO20081488L true NO20081488L (no)	2008-03-26

Family

ID=37561306

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20081488A NO20081488L (no)	2005-09-29	2008-03-26	Fotostabil farmasoytisk sammensetning inneholdende brivudine til behandling av herpetisk keratitt

Country Status (33)

Country	Link
US (1)	US20080249061A1 (de)
EP (1)	EP1940353B1 (de)
JP (1)	JP2009509993A (de)
KR (1)	KR20080053319A (de)
CN (1)	CN101272765A (de)
AP (1)	AP2008004394A0 (de)
AR (1)	AR056551A1 (de)
AT (1)	ATE489076T1 (de)
AU (1)	AU2006299115A1 (de)
BR (1)	BRPI0616449A2 (de)
CA (1)	CA2624111A1 (de)
CR (1)	CR9839A (de)
CY (1)	CY1111059T1 (de)
DE (2)	DE102005046769A1 (de)
DK (1)	DK1940353T3 (de)
EA (1)	EA012975B1 (de)
EC (1)	ECSP088310A (de)
ES (1)	ES2356774T3 (de)
HN (1)	HN2008000497A (de)
HR (1)	HRP20110085T1 (de)
IL (1)	IL190466A0 (de)
MA (1)	MA29887B1 (de)
NO (1)	NO20081488L (de)
PE (1)	PE20070767A1 (de)
PL (1)	PL1940353T3 (de)
PT (1)	PT1940353E (de)
RS (1)	RS51615B (de)
SI (1)	SI1940353T1 (de)
TN (1)	TNSN08094A1 (de)
TW (1)	TW200744664A (de)
UA (1)	UA90911C2 (de)
WO (1)	WO2007039201A2 (de)
ZA (1)	ZA200802729B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2009006130A2 (en) *	2007-06-28	2009-01-08	Bausch & Lomb Incorporated	Salt free hyaluronate ophthalmic solution
WO2009100367A2 (en) *	2008-02-06	2009-08-13	Adherex Technologies Inc.	Compositions comprising topical dpd inhibitors and methods of using same in the treatment of hand-foot syndrome
DE102009003942A1 (de) *	2009-01-07	2010-07-08	D2O Biosience Group Ltd., Hamilton	Verwendung von Deuteriumoxid zur Behandlung Virus-basierter Erkrankungen des Auges
RS58731B1 (sr)	2014-01-22	2019-06-28	Visufarma B V	Kompozicija koja sadrži jota-karagenan protiv virusnog konjuktivitisa
EP3452093B1 (de) *	2016-05-06	2021-04-28	Sacsh Corp.	Ophthalmische zusammensetzungen
CN113712928A (zh) *	2021-09-29	2021-11-30	重庆市力扬医药开发有限公司	经口腔粘膜吸收的溴夫定药物
EP4623919A1 (de)	2024-03-28	2025-10-01	Marinomed Biotech AG	Iota-carrageenan enthaltende zusammensetzung zur behandlung von trockenem auge, nichtviraler konjunktivitis und allergischen augenerkrankungen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY136633A (en) *	2001-01-17	2008-11-28	Berlin Chemie Ag	Stabilized brivudine topical formulations
DE10162593A1 (de) *	2001-12-19	2003-07-03	Menarini Ricerche Spa	Stabilisierte topische Brivudin-Formulierungen

2005
- 2005-09-29 DE DE102005046769A patent/DE102005046769A1/de not_active Withdrawn
2006
- 2006-09-27 ES ES06805904T patent/ES2356774T3/es active Active
- 2006-09-27 TW TW095135667A patent/TW200744664A/zh unknown
- 2006-09-27 EA EA200800646A patent/EA012975B1/ru not_active IP Right Cessation
- 2006-09-27 RS RS20110016A patent/RS51615B/sr unknown
- 2006-09-27 DK DK06805904.7T patent/DK1940353T3/da active
- 2006-09-27 ZA ZA200802729A patent/ZA200802729B/xx unknown
- 2006-09-27 WO PCT/EP2006/009383 patent/WO2007039201A2/en not_active Ceased
- 2006-09-27 BR BRPI0616449-8A patent/BRPI0616449A2/pt not_active IP Right Cessation
- 2006-09-27 AU AU2006299115A patent/AU2006299115A1/en not_active Abandoned
- 2006-09-27 JP JP2008532659A patent/JP2009509993A/ja not_active Withdrawn
- 2006-09-27 AT AT06805904T patent/ATE489076T1/de active
- 2006-09-27 UA UAA200802782A patent/UA90911C2/ru unknown
- 2006-09-27 EP EP06805904A patent/EP1940353B1/de active Active
- 2006-09-27 CN CNA2006800356965A patent/CN101272765A/zh active Pending
- 2006-09-27 AP AP2008004394A patent/AP2008004394A0/xx unknown
- 2006-09-27 PL PL06805904T patent/PL1940353T3/pl unknown
- 2006-09-27 CA CA002624111A patent/CA2624111A1/en not_active Abandoned
- 2006-09-27 PT PT06805904T patent/PT1940353E/pt unknown
- 2006-09-27 DE DE602006018505T patent/DE602006018505D1/de active Active
- 2006-09-27 US US12/088,397 patent/US20080249061A1/en not_active Abandoned
- 2006-09-27 KR KR1020087007483A patent/KR20080053319A/ko not_active Withdrawn
- 2006-09-27 HR HR20110085T patent/HRP20110085T1/hr unknown
- 2006-09-27 SI SI200630913T patent/SI1940353T1/sl unknown
- 2006-09-28 PE PE2006001181A patent/PE20070767A1/es not_active Application Discontinuation
- 2006-09-28 AR ARP060104294A patent/AR056551A1/es unknown
2008
- 2008-02-28 TN TNP2008000094A patent/TNSN08094A1/en unknown
- 2008-03-25 EC EC2008008310A patent/ECSP088310A/es unknown
- 2008-03-26 NO NO20081488A patent/NO20081488L/no not_active Application Discontinuation
- 2008-03-27 HN HN2008000497A patent/HN2008000497A/es unknown
- 2008-03-27 IL IL190466A patent/IL190466A0/en unknown
- 2008-03-27 CR CR9839A patent/CR9839A/es not_active Application Discontinuation
- 2008-04-24 MA MA30877A patent/MA29887B1/fr unknown
2010
- 2010-12-23 CY CY20101101189T patent/CY1111059T1/el unknown

Also Published As

Publication number	Publication date
HRP20110085T1 (hr)	2011-03-31
PL1940353T3 (pl)	2011-05-31
BRPI0616449A2 (pt)	2011-06-21
WO2007039201A3 (en)	2007-10-04
RS51615B (sr)	2011-08-31
TW200744664A (en)	2007-12-16
ZA200802729B (en)	2009-09-30
WO2007039201A2 (en)	2007-04-12
AR056551A1 (es)	2007-10-10
EP1940353A2 (de)	2008-07-09
SI1940353T1 (sl)	2011-03-31
HN2008000497A (es)	2010-09-10
US20080249061A1 (en)	2008-10-09
AU2006299115A1 (en)	2007-04-12
IL190466A0 (en)	2008-11-03
KR20080053319A (ko)	2008-06-12
UA90911C2 (ru)	2010-06-10
DE602006018505D1 (de)	2011-01-05
CY1111059T1 (el)	2015-06-11
MA29887B1 (fr)	2008-10-03
AU2006299115A2 (en)	2008-05-29
JP2009509993A (ja)	2009-03-12
CN101272765A (zh)	2008-09-24
DE102005046769A1 (de)	2007-04-05
TNSN08094A1 (en)	2009-07-14
CR9839A (es)	2008-10-31
CA2624111A1 (en)	2007-04-12
ECSP088310A (es)	2008-05-30
EP1940353B1 (de)	2010-11-24
ES2356774T3 (es)	2011-04-13
PE20070767A1 (es)	2007-08-13
PT1940353E (pt)	2011-02-25
EA012975B1 (ru)	2010-02-26
EA200800646A1 (ru)	2008-10-30
ATE489076T1 (de)	2010-12-15
AP2008004394A0 (en)	2008-04-30
DK1940353T3 (da)	2011-01-24

Legal Events

Date	Code	Title	Description
2012-04-30	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20081488L (no)	2008-03-26	Fotostabil farmasoytisk sammensetning inneholdende brivudine til behandling av herpetisk keratitt
NO20081479L (no)	2008-05-16	7-(2-Amino-1-hydroksyetyl)-4-hydroksybenzotiazol-2(3H)-ondenvater som beta2-adrenoceptoragonister
NO20074703L (no)	2007-11-14	Antibakterielle piperidinderivater
NO20081729L (no)	2008-05-16	Nye diazaspiroalkaner og deres anvendelse for behandling av CCR8-medierte sykdommer
WO2006015943A3 (en)	2007-02-08	Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
DK1863812T3 (da)	2010-10-18	Dipeptidylpeptidase-IV-inhiberende forbindelser, fremgangsmåder til fremstilling af de samme og farmaceutiske sammensætninger indeholdende de samme som aktive midler
NO20054776L (no)	2005-10-17	Kontrollert frigivelsessystem som inneholder sakkaroseacctatisobutyrat
WO2008079159A3 (en)	2008-10-09	Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases
NO20072939L (no)	2007-08-08	Makroloner - aminosubstituerte kinoloner
EP2308867A3 (de)	2011-10-19	2-Oxo-1-pyrrolidin-Derivate, Verfahren zu deren Herstellung und deren Verwendungen
PH12014500051A1 (en)	2015-01-12	New formulation
AR054114A1 (es)	2007-06-06	Composiciones farmaceuticas que comprenden imatinib y un retardador de la liberacion
NO20090346L (no)	2009-02-19	Pyrazolderivater som inhibitorer av cytokrom P450
NO20073572L (no)	2007-09-12	Nye forbindelser
NO20080158L (no)	2008-03-04	Oyedraper som inneholder roflumilast
NO20091999L (no)	2009-07-06	MAPK/ERK kinase inhibitorer
WO2007090661A3 (en)	2007-09-20	Active substance combination comprising azolylcarbinol compounds
DK1864666T3 (da)	2012-10-29	Beskyttelsesmiddel til en retinal neuronal celle indeholdende prostaglandin-F2-alfa-derivat som aktiv ingrediens
NO20055631L (no)	2005-11-29	Doseringsform inneholdende pantoprazol som aktiv ingrediens
WO2006002077A3 (en)	2006-11-16	Stable pharmaceutical formulations of benzimidazole compounds
WO2006120563A3 (en)	2007-04-12	Antibacterial agents
DK1729732T3 (da)	2009-08-10	Anioniske hydrogelmatricer med pH-afhængig frigivelse som lægemiddelbærere
NO20082129L (no)	2008-08-28	Middel til nedbrytning av nukleinsyrer samt fremgangsmate for nedbrytning av nukleinsyrer
WO2009109990A3 (en)	2009-12-10	Pramipexole composition comprising sugar alcohol(s)
TW200640932A (en)	2006-12-01	Clopidogrel base suitable for pharmaceutical formulation and preparation thereof